Welcome to the Biosafety Office
The University of Cincinnati Biosafety Office is responsible for performing risk assessments to identify hazards and to guide researchers in implementing practices and procedures that will minimize or eliminate risks associated with research involving biohazardous materials. It is charged with ensuring compliance with institutional requirements and federal, state and local regulations pertaining to the possession, use and transfer of biohazardous agents.
The Biosafety Office provides administrative support to the Institutional Biosafety Committee (IBC) which is charged with reviewing and approving all University research activities involving the use of biohazardous materials and recombinant or synthetic nucleic acid molecules, as described in the National Institutes for Health “Guidelines for Research Involving the Use of Recombinant or Synthetic Nucleic Acid Molecules” (NIH Guidelines) and the current edition of the Centers for Disease Control and Prevention’s “Biohazards in Microbiological and Biomedical Laboratories” (the “BMBL” or CDC Guidelines).
The Biosafety Office and IBC work closely to ensure the safety and health of research staff and compliance with applicable laws.
51 Goodman Drive, suite 300 Cincinnati, Ohio 45221